(Q48770244)

15 February 2018

title

Benzodiazepine-GABAA receptor complex ligands in two models of anxiety. (English)

1 reference

15 February 2018

3

A Płaźnik

1 reference

15 February 2018

author name string

M Nazar

series ordinal

1

1 reference

15 February 2018

M Jessa

series ordinal

2

1 reference

15 February 2018

publication date

1 January 1997

1 reference

15 February 2018

Journal of Neural Transmission

published in

1 reference

15 February 2018

volume

104

1 reference

15 February 2018

issue

6-7

1 reference

15 February 2018

page(s)

733-746

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/bf01291890

exact match

0 references

cites work

Long-term treatment with abecarnil fails to induce tolerance in mice

1 reference

12 December 2020

Effects of drugs on punished behavior: pre-clinical test for anxiolytics

1 reference

12 December 2020

Effects of antagonists at the NMDA receptor complex in two models of anxiety.

1 reference

12 December 2020

Evidence for central benzodiazepine receptor heterogeneity from behavior tests.

1 reference

12 December 2020

Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero.

1 reference

12 December 2020

Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibits low tolerance and dependence liabilities in the rat

1 reference

12 December 2020

Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes

1 reference

12 December 2020

Abecarnil enhances GABA-induced currents in acutely isolated cerebellar Purkinje cells.

1 reference

12 December 2020

Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain

1 reference

12 December 2020

Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.

1 reference

12 December 2020

The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety.

1 reference

12 December 2020

Pharmacological and behavioral profile of alpidem as an anxiolytic

1 reference

12 December 2020

The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety

1 reference

12 December 2020

Putative benzodiazepine partial agonists demonstrate receptor heterogeneity

1 reference

12 December 2020

Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor

1 reference

12 December 2020

Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic

1 reference

12 December 2020

Biological function of GABAA/benzodiazepine receptor heterogeneity

1 reference

12 December 2020

Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.

1 reference

12 December 2020

Regional differences in rat benzodiazepine binding in response to novelty and cat odour.

1 reference

12 December 2020

Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates

1 reference

12 December 2020

Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.

1 reference

12 December 2020

The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands.

1 reference

12 December 2020

Pharmacology of tolerance to benzodiazepine receptor ligands

1 reference

12 December 2020

Abecarnil is a full agonist at some, and a partial agonist at other recombinant GABAA receptor subtypes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01291890

1 reference

15 February 2018

1 reference

15 February 2018